NAICS Industry

NAICS 325411 Federal Contract Obligations (Last 10 Years)

Federal procurement activity under NAICS 325411, Medicinal and Botanical Manufacturing, totals $39.27 billion across 1,848,188 award actions over the last 10 years.

This NAICS page summarizes federal obligations for medicinal and botanical manufacturing, with the Defense Logistics Agency accounting for most spending and the Centers for Disease Control and Prevention a distant second. Vendor activity is concentrated in McKesson Corporation and AmerisourceBergen Drug-related entries, while annual obligations have remained in the multibillion-dollar range in each recent year shown.

Generated at 03/21/2026

Analysis period: Last 10 years

Vendor names may appear as separate entries even when the CAGE code matches, so totals should be reviewed with that in mind.

NAICS Code
325411
Industry
MEDICINAL AND BOTANICAL MANUFACTURING
Total Obligated
39.27 billion
39,267,601,833.98
Award Actions
1,848,188
Average Action Value
21,246.54

About NAICS 325411 federal contract activity

NAICS 325411, Medicinal and Botanical Manufacturing, recorded $39.27 billion in obligations across 1,848,188 awards over the last 10 years, with an average award value of $21,246.54. The activity profile is characterized by very high transaction volume alongside a relatively concentrated share of dollars in a small number of major suppliers.

Agency demand and leading federal buyers

The Defense Logistics Agency dominates this category with $37.45 billion and 1,846,586 awards, accounting for nearly all reported obligations and transaction volume. The Centers for Disease Control and Prevention is the only other major funding source at $1.67 billion, while the Department of State, the Department of the Army, and the Bureau of Land Management contribute comparatively modest amounts.

Vendor concentration and leading contractors

MCKESSON CORPORATION leads suppliers with $19.54 billion across 309,587 awards, followed by AMERISOURCEBERGEN DRUG CORP at $12.01 billion. AMERISOURCEBERGEN DRUG CORPORATION appears separately with the same CAGE code and additional obligations, indicating vendor-name variation that fragments spend across records; MERCK SHARP & DOHME CORP. and DMS PHARMACEUTICAL GROUP INC. round out the top vendors.

Annual contract trend over the analysis window

Annual obligations remained in the multi-billion-dollar range throughout the reported period, rising from $3.52 billion in 2021 to $4.88 billion in 2025. Award counts also remained high, with 2023 and 2022 showing the largest volumes in the series provided, suggesting sustained procurement activity rather than isolated spikes.

How to interpret this page

This page summarizes FPDS obligations for NAICS 325411 over the last 10 years using total obligated dollars, award counts, and average award value. Vendor and agency rankings reflect reported FPDS records as provided, and vendor entries are displayed as captured, including distinct name variants associated with the same CAGE code.

Top Agencies

SELECT
    agency_id,
    agency_name,
    total_obligated,
    award_count,
    formatReadableQuantity(total_obligated) AS total_obligated_readable
FROM
(
    SELECT
        content__award__purchaserInformation__contractingOfficeAgencyID AS agency_id,
        anyHeavy(content__award__purchaserInformation__contractingOfficeAgencyID__name) AS agency_name,
        sum(content__award__dollarValues__obligatedAmount) AS total_obligated,
        count() AS award_count
    FROM fpds.data
    WHERE
        contract_type = 1
        AND content__award__productOrServiceInformation__principalNAICSCode = '325411'
        AND content__award__purchaserInformation__contractingOfficeAgencyID IS NOT NULL
        AND content__award__purchaserInformation__contractingOfficeAgencyID != ''
        AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) >= toStartOfYear(now()) - INTERVAL 10 YEAR
        AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) < toStartOfYear(now())
    GROUP BY agency_id
)
ORDER BY total_obligated DESC
LIMIT 10
Agency ID Agency Name Total Obligated Readable Award Actions
97AS DEFENSE LOGISTICS AGENCY 37,447,673,001.43 37.45 billion 1,846,586
7523 CENTERS FOR DISEASE CONTROL AND PREVENTION 1,671,675,608.90 1.67 billion 182
1900 STATE, DEPARTMENT OF 49,601,320.01 49.60 million 217
2100 DEPT OF THE ARMY 43,523,248.97 43.52 million 62
1422 BUREAU OF LAND MANAGEMENT 17,985,033.57 17.99 million 54
7529 NATIONAL INSTITUTES OF HEALTH 17,164,933.88 17.16 million 217
3600 VETERANS AFFAIRS, DEPARTMENT OF 9,148,992.29 9.15 million 343
97DH DEFENSE HEALTH AGENCY (DHA) 2,930,052.83 2.93 million 53
7505 OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE 2,803,999.91 2.80 million 12
6800 ENVIRONMENTAL PROTECTION AGENCY 1,020,087.95 1.02 million 23

Insight

Over the last 10 years, obligations under NAICS 325411 are highly concentrated in the Defense Logistics Agency, which accounts for $37.45 billion of the $39.27 billion total and 1,846,586 of 1,848,188 awards. The Centers for Disease Control and Prevention is a distant second at $1.67 billion, while all other agencies each obligated less than $50 million. This indicates a procurement profile dominated by a single agency, with limited dollar dispersion across the remaining top obligators.

Top Vendors

SELECT
    vendor_name,
    cage_code,
    total_obligated,
    award_count,
    formatReadableQuantity(total_obligated) AS total_obligated_readable
FROM
(
    SELECT
        content__award__vendor__vendorHeader__vendorName AS vendor_name,
        anyHeavy(content__award__vendor__vendorSiteDetails__entityIdentifiers__cageCode) AS cage_code,
        sum(content__award__dollarValues__obligatedAmount) AS total_obligated,
        count() AS award_count
    FROM fpds.data
    WHERE
        contract_type = 1
        AND content__award__productOrServiceInformation__principalNAICSCode = '325411'
        AND content__award__vendor__vendorHeader__vendorName IS NOT NULL
        AND content__award__vendor__vendorHeader__vendorName != ''
        AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) >= toStartOfYear(now()) - INTERVAL 10 YEAR
        AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) < toStartOfYear(now())
    GROUP BY vendor_name
)
ORDER BY total_obligated DESC
LIMIT 10
Vendor CAGE Code Total Obligated Readable Award Actions
MCKESSON CORPORATION 0U9U0 19,535,374,470.83 19.54 billion 309,587
AMERISOURCEBERGEN DRUG CORP 1XUY5 12,009,005,480.66 12.01 billion 231,023
AMERISOURCEBERGEN DRUG CORPORATION 1XUY5 5,220,903,744.59 5.22 billion 1,099,406
MERCK SHARP & DOHME CORP. 6B2S4 1,480,197,593.88 1.48 billion 28
DMS PHARMACEUTICAL GROUP INC. 1UNB0 426,058,524.40 426.06 million 96,202
GLAXOSMITHKLINE LLC 667E9 138,252,360.04 138.25 million 51
EMERGENT BIODEFENSE OPERATIONS LANSING LLC 1H0B6 59,370,310.00 59.37 million 9
CARDINAL HEALTH, INC. 00E55 57,920,369.17 57.92 million 22,098
SAGENT PHARMACEUTICALS, INC. 4RP13 50,731,056.16 50.73 million 255
3M COMPANY 76381 27,923,518.65 27.92 million 2,160

Insight

Obligations in NAICS 325411 over the last 10 years are highly concentrated among a small set of vendors. McKesson Corporation and the two AmerisourceBergen entries together account for the majority of reported obligations, indicating significant dependence on a few large pharmaceutical distributors. Award activity is also uneven: AmerisourceBergen Drug Corporation reports the highest award volume, while Merck Sharp & Dohme and GlaxoSmithKline show relatively high obligated amounts on very low award counts, suggesting a mix of bulk distribution and discrete high-value buys.

Annual Trend

SELECT
    year,
    total_obligated,
    award_count,
    formatReadableQuantity(total_obligated) AS total_obligated_readable
FROM
(
    SELECT
        toYear(parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate)) AS year,
        sum(content__award__dollarValues__obligatedAmount) AS total_obligated,
        count() AS award_count
    FROM fpds.data
    WHERE
        contract_type = 1
        AND content__award__productOrServiceInformation__principalNAICSCode = '325411'
        AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) >= toStartOfYear(now()) - INTERVAL 10 YEAR
        AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) < toStartOfYear(now())
    GROUP BY year
)
ORDER BY year DESC
Year Total Obligated Readable Award Actions
2025 4,881,830,691.01 4.88 billion 112,488
2024 4,509,138,491.41 4.51 billion 165,157
2023 3,399,562,860.06 3.40 billion 177,993
2022 3,354,851,884.41 3.35 billion 165,731
2021 3,523,363,215.14 3.52 billion 176,051
2020 3,652,285,136.45 3.65 billion 203,388
2019 3,666,695,670.11 3.67 billion 222,666
2018 3,568,437,699.02 3.57 billion 218,449
2017 5,157,125,420.38 5.16 billion 205,647
2016 3,554,310,765.99 3.55 billion 200,618

Insight

Over the last 10 years, NAICS 325411 accumulated $39.27 billion across 1,848,188 awards, with an average award value of $21,246.54, indicating a high-volume, generally low-dollar obligation pattern. Annual obligations were relatively stable from 2016 through 2024, mostly ranging from about $3.35 billion to $3.67 billion, with a single higher point in 2017 at $5.16 billion. In 2025, obligations rose to $4.88 billion, remaining above the prior-year level and continuing the upward movement from 2023–2024. Award counts were highest in 2019 and 2018, then declined in 2024–2025, suggesting fewer awards but higher annual obligated dollars in the most recent period.

Use FPDS Query for deeper industry analysis

Explore federal procurement data with custom SQL, fast filtering, and deeper industry analysis across agencies, vendors, and annual trends.

Continue from this last 10 years view into full FPDS Query workflows with deeper filtering, custom SQL, saved queries, and broader market comparison.